PCSK9 and myocardial infarction: Mutations of PCSK9 leading to reduced expression and or function of PCSK9 are associated with a reduced rate of coronary heart disease [37] (Fig. 6), myocardial infarction [63] and overall cardiovascular events [143], an effect being more pronounced in black as compared to white subjects [37].